株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医療機器:各種技術と世界市場

Medical Devices: Technologies and Global Markets

発行 BCC Research 商品コード 311939
出版日 ページ情報 英文 316 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.79円で換算しております。
Back to Top
医療機器:各種技術と世界市場 Medical Devices: Technologies and Global Markets
出版日: 2016年12月21日 ページ情報: 英文 316 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の各種医療機器の市場は2016年から2021年にかけて5.6%のCAGR (年間複合成長率) で推移し、2015年の4583億ドルから、2016年には4835億ドル、2021年には6345億ドルの規模に成長すると予測されています。

当レポートは、世界の各種医療機器の技術と市場を調査し、市場の定義と概要、市場の現状、市場成長への各種影響因子および市場機会の分析、製品・技術の詳細区分別の動向、市場規模の推移と予測、市場シェア、地域市場の分析、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 医療機器技術業界における技術革新
  • 医療機器技術業界における現況
  • 医療技術の定義・発展・各種タイプ
  • 法規制:地域別
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
  • 戦略
  • 流通網:地域別
  • 動向
  • 新製品・技術
  • 新材料
  • 修理・買い替え市場
  • M&A
  • 提言

第4章 世界の医療機器技術の市場

  • 概要
  • 画像装置
    • MRI
    • 超音波
    • レーザー
    • IVR
    • X線
    • CT
    • PET
    • POC技術
  • IVD用デバイス
  • 免疫化学
  • ポイントオブケア診断
  • 分子診断
    • 薬理ゲノミクス
    • POC検査
  • 血液検査
  • 心臓血管デバイス
    • 介入性デバイス
    • 心調律管理
    • 心臓カテーテル技術
  • 整形外科・脊椎関連
    • 再建インプラント
    • 脊椎インプラント
    • 外傷固定デバイス技術
  • 泌尿科デバイス
    • 医療用レーザーシステム
    • 失禁関連デバイス
    • 腎透析デバイス
  • 内視鏡装置
    • 硬性鏡
    • 軟性鏡
  • ドラッグデリバリー関連
    • 注入システム
    • 吸入器
    • 無針注射・経皮システム、など

第5章 医療機器技術の市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中国
  • その他

第6章 競合環境

第7章 企業プロファイル

  • 3M
  • ABBOTT LABORATORIES
  • AGILENT TECHNOLOGIES
  • BAYER
  • BAXTER INTERNATIONAL
  • BECKTON, DICKINSON AND CO.
  • BOSTON SCIENTIFIC
  • CARDINAL HEALTH
  • COVIDIEN
  • DANAHER
  • DRAGER
  • FRESENIUS
  • GE HEALTHCARE
  • GETINGE AB
  • HALYARD HEALTH, INC.
  • HOSPIRA
  • JOHNSON & JOHNSON
  • MEDTRONIC
  • NOVARTIS
  • オリンパス
  • PALL CORP.
  • PHILIPS HEALTHCARE
  • ROCHE DIAGNOSTICS
  • SAINT JUDE MEDICAL
  • SIEMENS HEALTHCARE
  • SMITH & NEPHEW
  • SMITHS MEDICAL
  • STRYKER CORP.
  • SYNTHES
  • TELEFLEX
  • THERMO FISHER SCIENTIFIC
  • 東芝メディカルシステムズ
  • ZIMMER HOLDINGS

第8章 特許分析

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HLC170B

REPORT HIGHLIGHTS

The global market for medical device technologies reached $458.3 billion in 2015. The market should reach $483.5 billion in 2016 and $634.5 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.6% from 2016 to 2021.

This report provides:

  • An overview of the global medical devices markets.
  • Analyses of global market trends with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Discussion of definitions, evolution and types of devices, regulations and legislations, as well as key industry aspects such as market drivers and industry strategies.
  • Information on the refurbished and replacement market, mergers and acquisitions, market shares for key players, and trends broken down by geography, new technology, and new materials used.
  • An in-depth breakdown of devices by technology type including: imaging devices, in-vitro diagnostic devices, cardiovascular devices, orthopedic and spine, urology and renal devices, endoscopic devices, and drug delivery systems.
  • Profiles of major players in the industry.

SCOPE OF THE REPORT

This research report incorporates an in-depth analysis of the medical device technology market, including market estimations and trends through 2018. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report also examines recent developments and product portfolios of the major players, along with their market shares. Patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for medical device technologies.

The scope of the report extends to only those medical device technologies that generate the most global revenue. Dental device technologies and some imaging devices used in dentistry overlap with other devices already covered under the imaging device technologies segments, so they have been excluded.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • MARKET DESCRIPTION
  • SCOPE OF THE REPORT
  • INTENDED AUDIENCE
  • RESEARCH METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, 2015-2021 ($ MILLIONS)

CHAPTER 3 - MARKET OVERVIEW

  • INNOVATIONS IN THE MEDICAL DEVICE TECHNOLOGY INDUSTRY
  • CURRENT TRENDS IN THE MEDICAL DEVICE TECHNOLOGY INDUSTRY
  • DEFINITION, EVOLUTION AND TYPES OF MEDICAL TECHNOLOGIES
    • DEFINITION
    • EVOLUTION
    • TYPES
      • Imaging Systems
      • In vitro Diagnostics
      • Cardiovascular Disease Procedures
      • Orthopedic and Spinal Procedures
  • REGULATIONS AND LEGISLATIONS
    • EUROPE
      • Restriction of Hazardous Substances II
    • U.S.
    • CHINA
    • JAPAN
    • INDIA
    • OTHERS
      • Indonesia
      • South Korea
      • Malaysia
      • Philippines
      • Singapore
      • Taiwan
      • Australia
      • Hong Kong
      • Vietnam
  • MARKET DYNAMICS
    • DRIVERS
      • Aging Global Population
        • FIGURE 1: GLOBAL POPULATION OLDER THAN AGE 60 BY REGION, 2013
      • Increase in Lifestyle and Chronic Diseases
        • FIGURE 2: GLOBAL PROJECTED GROWTH OF DIABETES INCIDENCES IN PATIENTS AGE 20-79, 2010 AND 2030 (%)
      • Molecular Medicine and Minimally Invasive Techniques
      • Other Drivers
    • RESTRAINTS
    • OPPORTUNITIES
  • STRATEGIES
  • DISTRIBUTION NETWORK
    • ASIA-PACIFIC
    • U.S.
    • EUROPE
    • INDIA
    • CHINA
    • OTHERS
      • Japan
      • South Korea
  • TRENDS
    • CHINA
    • EUROPE
  • NEW PRODUCTS AND TECHNOLOGIES
  • NEW MATERIALS
  • REFURBISHED AND REPLACEMENT MARKET
  • MERGERS AND ACQUISITIONS
  • RECOMMENDATIONS

CHAPTER 4 - GLOBAL MEDICAL DEVICE TECHNOLOGY MARKET

  • OVERVIEW
    • TABLE 1: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGY BY SEGMENT, THROUGH 2021 ($ MILLIONS)
  • IMAGING DEVICES
    • TABLE 2: GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • MARKET DYNAMICS
      • Increased Life Expectancy
      • Growing Incidence of Diseases
      • Improvement in Medical Device Technologies
      • Legislative Amendments and Other Initiatives
      • Resistance to New Technology-Based Systems Due to High Costs
      • Excise Duties Levied Under the Patient Protection and Affordable Care Act
      • Large Population Base in Emerging Economies
      • Increasing Government Spending on Healthcare and Healthcare Infrastructure
        • TABLE 3: GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • MAGNETIC IMAGING RESONANCE
      • Market Dynamics
        • FIGURE 3: GLOBAL INCIDENCE OF PATIENTS WITH CHRONIC DISEASES, 2005-2030 (MILLIONS)
        • TABLE 4: GLOBAL MARKET FOR MAGNETIC IMAGING RESONANCE TECHNOLOGY BY REGION,THROUGH 2021 ($ MILLIONS)
      • Innovation and New Products
        • GE Healthcare
        • Toshiba
        • Siemens
        • Hitachi
        • Philips
      • Trends
        • FIGURE 4: GLOBAL MARKET SHARES OF KEY COMPANIES IN MAGNETIC IMAGING RESONANCE TECHNOLOGIES, 2015 (%)
    • ULTRASOUND TECHNOLOGY MARKET
      • Market Dynamics
        • FIGURE 5: COUNTRIES WITH THE HIGHEST PERCENTAGE OF PEOPLE AGE 60 AND OLDER, 2011
        • FIGURE 6: COUNTRIES WITH THE HIGHEST EXPECTED PERCENTAGE OF PEOPLE AGE 60 AND OLDER, 2050
      • New Product Innovations
      • Market Trends
        • TABLE 5: GLOBAL MARKET FOR ULTRASOUND TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
        • FIGURE 7: GLOBAL MARKET SHARES OF ULTRASOUND TECHNOLOGIES BY COMPANY, 2015 (%)
    • LASER IMAGING MARKET
      • TABLE 6: GLOBAL MARKET FOR LASER IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 8: GLOBAL PREVALENCE OF ALZHEIMER'S DISEASE BY REGION, 2010-2050
      • New Product Innovations
      • Market Trends
        • FIGURE 9: GLOBAL MARKET SHARES FOR LASER IMAGING BY COMPANY, 2015 (%)
    • INTERVENTIONAL RADIOLOGY MARKET
      • TABLE 7: GLOBAL MARKET FOR INTERVENTIONAL RADIOLOGY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 10: GLOBAL ANGIOPLASTY PROCEDURES, 2009-2012
        • FIGURE 11: GLOBAL STENTS USED IN CORONARY PROCEDURES, 2009-2012 (NO. OF STENTS)
      • Innovation and New Products
        • Market Trends
      • X-RAY
        • TABLE 8: GLOBAL MARKET FOR X-RAY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 12: PICTURE ARCHIVING AND COMMUNICATION SYSTEM PROCESS FOR OBTAINING IMAGES
        • FIGURE 13: GLOBAL POPULATION BY AGE GROUP, 2000 AND 2050 (%)
        • TABLE 9: TARGET DISEASE STATISTICS
      • Innovation and New Products
      • Market Trends
        • FIGURE 14: GLOBAL MARKET SHARES FOR X-RAY SYSTEMS BY COMPANY, 2015 (%)
    • COMPUTER TOMOGRAPHY
      • TABLE 10: GLOBAL MARKET FOR COMPUTER TOMOGRAPHY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 15: CORONARY HEART DISEASE IN SELECTED COUNTRIES, 2012 (%)
      • Innovation and New Products
        • GE Healthcare
        • Phillips
    • NUCLEAR MEDICINE AND POSITRON EMISSION TOMOGRAPHY (PET)
      • TABLE 11: GLOBAL MARKET FOR NUCLEAR MEDICINE/PET TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 16: GLOBAL CARDIOVASCULAR MORTALITY BY INCOME LEVEL, 2011 (%)
      • Innovation and New Products
      • Market Trends
        • TABLE 12: GLOBAL MARKET FOR POINT-OF-CARE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Share of Key Players
    • POINT-OF-CARE TECHNOLOGIES
      • TABLE 13: GLOBAL MARKET FOR POINT-OF-CARE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
      • Innovation and New Products
      • Market Trends
      • Market Share of Key Players
    • IN VITRO DIAGNOSTIC DEVICES
      • TABLE 14: GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • MARKET DYNAMICS
      • FIGURE 17: HEALTHCARE EXPENDITURES IN THE U.S., CHINA AND INDIA, 2009-2011
      • Overall In Vitro Diagnostics Market Share
        • FIGURE 18: GLOBAL MARKET SHARES FORIN VITRO DIAGNOSTICS BY COMPANY, 2015 (%)
      • Professional In Vitro Diagnostics Market Share
        • FIGURE 19: GLOBAL MARKET SHARES FOR PROFESSIONAL DIAGNOSTICS BY COMPANY, 2015 (%)
      • In Vitro Diagnosis Types
        • Immunoassays
        • Diabetes Testing
        • Blood Testing and Hematology
        • Molecular Diagnosis
          • TABLE 15: GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY SEGMENTS, THROUGH 2021 ($ MILLIONS)
    • REGULATIONS
    • IN VITRO DIAGNOSTICS MARKET BY REGION
  • IMMUNOCHEMISTRY
    • TABLE 16: GLOBAL MARKET FOR IMMUNOCHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
  • MARKET DYNAMICS
    • FIGURE 20: CARDIOVASCULAR DISEASE IN SELECTED REGIONS, 2012 (%)
    • FIGURE 21: NEW GLOBAL HIV INFECTIONS BY REGION, 2012 (NO.)
  • INNOVATION AND NEW PRODUCTS
  • TRENDS
  • MARKET SHARE OF KEY PLAYERS
    • FIGURE 22: GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR INFECTIOUS DISEASES, 2015 (%)
    • FIGURE 23: GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR HEPATITIS AND RETROVIRUS, 2015 (%)
    • FIGURE 24: GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR ONCOLOGY AND ENDOCRINOLOGY, 2015 (%)
    • FIGURE 25: GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR NUCLEIC ACID TESTING, 2015
    • TABLE 17: GLOBAL MARKET FOR CLINICAL CHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
  • POINT-OF-CARE DIAGNOSTIC MARKET
    • TABLE 18: POINT-OF-CARE DIAGNOSTIC TESTS AND MANUFACTURERS
    • TABLE 19: DIABETES INCIDENCE IN THE TOP 10 COUNTRIES, 2013 (THOUSANDS)
    • FIGURE 26: GLOBAL PREVALENCE OF DIABETES BY AGE GROUP BY REGION, 2013 (THOUSANDS)
    • FIGURE 27: SHIFT IN USAGE OF POINT-OF-CARE DIAGNOSTIC SOLUTIONS
    • TABLE 20: GLOBAL MARKET FOR POINT-OF-CARE TESTING TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
  • INNOVATION AND NEW PRODUCTS
    • TRENDS
      • FIGURE 28: U.S. HOSPITAL HEALTHCARE SPENDING, 2010-2012 ($ BILLIONS)
      • TABLE 21: POINT-OF-CARE DIAGNOSTIC SOLUTIONS ACROSS PRODUCT SEGMENTS
    • COMPETITIVE LANDSCAPE
      • FIGURE 29: GLOBAL MARKET SHARES FOR POINT-OF-CARE DIAGNOSTICS BY COMPANY, 2015 (%)
    • MOLECULAR DIAGNOSTICS
      • TABLE 22: GLOBAL MARKET FOR MOLECULAR DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • GROWING GLOBAL PREVALENCE OF HOSPITAL-ACQUIRED AND HPV INFECTIONS
      • FIGURE 30: APPLICATION OF MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE SEGMENTS, 2015 (%)
    • PHARMACOGENOMICS
    • POINT-OF-CARE TESTING
    • MARKET TRENDS
      • U.S.
      • China
      • India
      • Overall Market Trends
    • COMPETITIVE LANDSCAPE
      • FIGURE 31: GLOBAL MARKET SHARES FOR MOLECULAR DIAGNOSTICS BY COMPANY, 2015 (%)
    • BLOOD TESTING
      • TABLE 23: GLOBAL MARKET FOR HEMATOLOGY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • MARKET TRENDS
      • U.S.
      • China
    • COMPETITIVE LANDSCAPE
  • CARDIOVASCULAR DEVICE MARKET
    • TABLE 24: GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • CARDIOVASCULAR DISEASE TYPES
      • Cardiac Arrhythmia
        • TABLE 25: ABLATION TYPES AND THEIR MECHANISMS
      • Coronary Blockages
        • TABLE 26: GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • MARKET DYNAMICS
      • FIGURE 32: GLOBAL POPULATION BY AGE GROUP, 2000 AND 2050 (%)
    • INTERVENTIONAL CARDIOLOGY DEVICES
      • Stents
        • FIGURE 33: EVOLUTION OF CORONARY STENTS
        • TABLE 27: INCIDENCE OF RESTENOSIS BY STENT TYPE, 2014 (%)
        • TABLE 28: DRUG-ELUTING STENT PRODUCTS AND MANUFACTURERS
        • TABLE 29: BIO-ABSORBABLE STENT PRODUCTS AND MANUFACTURERS
      • Percutaneous Transluminal Coronary Angioplasty Balloons
        • TABLE 30: COMPARATIVE ANALYSIS OF STENTS BY BALLOON PLATFORM
      • Percutaneous Transluminal Coronary Angioplasty Guidewires
      • Percutaneous Transluminal Coronary Angioplasty Guiding Catheters
      • Angiography Catheters
      • Balloon Inflation Devices
        • TABLE 31: MANUFACTURERS AND THEIR PRODUCTS
      • Intravascular Ultrasound
      • Cardiovascular Device Market Trends
  • REGULATIONS
    • CARDIAC RHYTHM MANAGEMENT MARKET
      • TABLE 32: GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 34: GLOBAL POPULATION BASE TO AGE 65 AND OLDER, 2000 AND 2050 (%)
      • Market Trends
        • Pharmacological Treatment
          • TABLE 33: ANTI-ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE
          • TABLE 34: ANTI-ARRHYTHMIC DRUG CLASSIFICATION AND CLINICAL USAGE
        • Non-Pharmacological Treatment
        • Maze Surgery Procedures
        • Electric Cardioversion Procedures
        • Global Market Trends
      • Competitive Rivalry
    • CARDIAC CATHETERIZATION TECHNOLOGIES
      • TABLE 35: GLOBAL MARKET FOR CARDIAC CATHETERIZATION TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
      • Innovation and New Products
    • ORTHOPEDIC AND SPINAL TECHNOLOGIES
      • TABLE 36: GLOBAL MARKET FOR ORTHOPEDIC AND SPINAL TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • MARKET DYNAMICS
    • REGION
      • TABLE 37: GLOBAL MARKET FOR ORTHOPEDIC AND SPINE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • REGULATIONS
    • RECONSTRUCTIVE IMPLANTS
      • TABLE 38: GLOBAL MARKET FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 35: OSTEOPOROTIC HIP FRACTURES BY REGION, 1990 AND 2050 (THOUSANDS)
      • Innovation and New Products
      • Trends
      • Market Share
        • FIGURE 36: GLOBAL MARKET SHARES FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY COMPANY, 2015 (%)
    • SPINAL IMPLANTS
      • TABLE 39: GLOBAL MARKET FOR SPINE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
      • Market Trends
        • TABLE 40: FDA AND CE APPROVALS OF SPINAL CORD STIMULATION DEVICES, 2001-2015
      • Innovation and New Products
      • Market Share Analysis
        • FIGURE 37: GLOBAL MARKET SHARES FOR SPINAL IMPLANT BY COMPANY, 2015 (%)
    • TRAUMA FIXATION DEVICE TECHNOLOGY MARKET
      • TABLE 41: GLOBAL MARKET FOR TRAUMA FIXATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Market Dynamics
        • FIGURE 38: GLOBAL MARKET SHARES FOR TRAUMA DEVICE FIXATION BY COMPANY, 2015
      • Orthopedic Robotic Systems
        • TABLE 42: GLOBAL MARKET FOR ROBOTIC SYSTEM TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • Major Orthopedic Robotic Systems
        • MAKO RIO Surgical System
        • Stanmore Sculptor Robotic Guidance Arm
        • NavioPFS Surgical System
        • iBlock Surgical System
        • ROBODOC Surgical System
  • UROLOGY DEVICE MARKET
    • TABLE 43: GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
  • MARKET DYNAMICS
    • TABLE 44: GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
  • MEDICAL LASER SYSTEMS FOR UROLOGY
    • TABLE 45: GLOBAL MARKET FOR LITHOTRIPTER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
  • REGIONS
    • FIGURE 39: GLOBAL PREVALENCE OF KIDNEY DISEASE BY REGION, 2012 (%)
  • REGULATIONS
  • INCONTINENCE DEVICES
    • Market Dynamics
      • FIGURE 40: LIFE EXPECTANCY AT BIRTH FOR SELECTED COUNTRIES, 2012 (YEARS)
    • Trends
      • TABLE 46: GLOBAL MARKET FOR INCONTINENCE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 41: GLOBAL POPULATION BASE AGE 60 AND OLDER, 2010-2017 (%)
    • Innovation and New Products
    • Market Shares
      • Ostomy Care Device Market
        • FIGURE 42: GLOBAL MARKET SHARES FOR OSTOMY CARE DEVICES BY COMPANY, 2015 (%)
      • Incontinence Care Device Market
        • FIGURE 43: GLOBAL MARKET SHARES FOR INCONTINENCE CARE DEVICES BY COMPANY, 2015 (%)
  • RENAL DIALYSIS DEVICE MARKET
    • TABLE 47: GLOBAL MARKET FOR RENAL DIALYSIS DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • FIGURE 44: GLOBAL MARKET SHARES FOR RENAL DIALYSIS DEVICES BY COMPANY, 2015
  • ENDOSCOPY DEVICES
    • TABLE 48: GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
  • TYPES
    • TABLE 49: GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
  • MARKET DYNAMICS
    • FIGURE 45: GLOBAL PREVALENCE OF COLON CANCER BY AGE, 2015
  • RIGID ENDOSCOPES
    • TABLE 50: GLOBAL MARKET FOR RIGID ENDOSCOPIC DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • Market Dynamics
  • FLEXIBLE ENDOSCOPES
    • TABLE 51: GLOBAL MARKET FOR FLEXIBLE ENDOSCOPIC DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • Market Dynamics
  • INNOVATION AND NEW PRODUCTS
  • DRUG DELIVERY DEVICES
    • TABLE 52: GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 53: GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
  • MARKET DYNAMICS
    • Increasing Prevalence of Cardiovascular Disease
    • Increasing Global Prevalence of Prostate Cancer
    • Emergence of New Disease Applications for Cervical Cancer and Breast Cancer
    • Growing Global Elderly Population Base
    • Rising Prevalence of Diabetes and Diabetic Retinopathy
    • Growing Prevalence of Unwanted Pregnancies
    • Government and Nongovernmental Organization Initiatives to Promote Contraceptive Products
    • Introduction of New and Advanced Implantable Drug Delivery Devices
    • Introduction of Biodegradable Technology Products
    • Product Recalls, Lawsuits and the Introduction of Internal Product Substitutes
    • Stringent FDA and CE Approval Norms
  • INFUSION SYSTEMS
    • TABLE 54: GLOBAL MARKET FOR INFUSION SYSTEM AND INJECTABLE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • Market Dynamics
      • Rising Global Prevalence of Colorectal Cancer
      • High Prevalence of Chronic Pain Causing Disorders
    • Innovation and New Products
    • Market Trends
  • INHALATION DEVICES
    • TABLE 55: GLOBAL MARKET FOR INHALATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • Market Dynamics
    • Innovation and New Products
    • Trends
  • NEEDLE-FREE INJECTIONS AND TRANSDERMAL SYSTEMS
    • TABLE 56: GLOBAL MARKET FOR NEEDLE-FREE INJECTION AND TRANSDERMAL SYSTEM TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • Market Dynamics
    • New Product Developments
    • Market Trends
      • TABLE 57: MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES

CHAPTER 5 - MEDICAL DEVICE TECHNOLOGIES MARKET BY REGION

  • NORTH AMERICA
    • TABLE 58: NORTH AMERICAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
  • EUROPE
    • TABLE 59: EUROPEAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
  • ASIA-PACIFIC
    • TABLE 60: ASIA-PACIFIC MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
  • CHINA
  • REST OF THE WORLD
    • TABLE 61: REST OF THE WORLD MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)

CHAPTER 6 - COMPETITIVE LANDSCAPE

  • TABLE 62: PRODUCT LAUNCHES AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016
  • TABLE 63: MERGERS AND ACQUISITIONS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET, JANUARY 2013-SEPTEMBER 2016
  • TABLE 64: AGREEMENTS, JOINT VENTURES, EXPANSIONS, DIVESTMENTS AND INVESTMENTS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016
  • TABLE 65: CERTIFICATION, REORGANIZATION, RESEARCH AND DEVELOPMENT FACILITIES, AND SERVICES AND SOLUTIONS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016
  • TABLE 66: CERTIFICATIONS AND SERVICES IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016
  • TABLE 67: REORGANIZATION, COLLABORATION, SPINOFFS, RESEARCH AND DEVELOPMENT AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016

CHAPTER 7 - COMPANY PROFILES

  • 3M
    • TABLE 68: 3M PRODUCT PORTFOLIO
    • TABLE 69: 3M DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • ABBOTT LABORATORIES
    • TABLE 70: ABBOTT LABORATORIES PRODUCT PORTFOLIO
    • TABLE 71: ABBOTT LABORATORIES DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • AGILENT TECHNOLOGIES
    • TABLE 72: AGILENT PRODUCT PORTFOLIO
    • TABLE 73: AGILENT DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • BAYER
    • TABLE 74: BAYER HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 75: BAYER HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • BAXTER INTERNATIONAL
    • TABLE 76: BAXTER INTERNATIONAL PRODUCT PORTFOLIO
    • TABLE 77: BAXTER INTERNATIONAL DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • BECKTON, DICKINSON AND CO.
    • TABLE 78: BECKTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
    • TABLE 79: BECKTON, DICKINSON AND COMPANY DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • BOSTON SCIENTIFIC
    • TABLE 80: BOSTON SCIENTIFIC PRODUCT PORTFOLIO
    • TABLE 81: BOSTON SCIENTIFIC DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • CARDINAL HEALTH
    • TABLE 82: CARDINAL HEALTH PRODUCT PORTFOLIO
    • TABLE 83: CARDINAL HEALTH DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • COVIDIEN
    • TABLE 84: COVIDIEN PRODUCT PORTFOLIO
    • TABLE 85: COVIDIEN DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • DANAHER
    • TABLE 86: DANAHER PRODUCT PORTFOLIO
    • TABLE 87: DANAHER DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • DRAGER
    • TABLE 88: DRAGER PRODUCT PORTFOLIO
    • TABLE 89: DRAGER DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • FRESENIUS
    • TABLE 90: FRESENIUS PRODUCT PORTFOLIO
    • TABLE 91: FRESENIUS DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • GE HEALTHCARE
    • TABLE 92: GE HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 93: GE HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • GETINGE AB
    • TABLE 94: GETINGE AB PRODUCT PORTFOLIO
    • TABLE 95: GETINGE AB DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • HALYARD HEALTH, INC.
    • TABLE 96: HALYARD HEALTH, INC. PRODUCT PORTFOLIO
    • TABLE 97: KIMBERLY-CLARK HEALTHCARE DEVELOPMENTS, JANUARY 2013-SEPTEMBER 2016
  • HOSPIRA
    • TABLE 98: HOSPIRA PRODUCT PORTFOLIO
    • TABLE 99: HOSPIRA DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • JOHNSON & JOHNSON
    • TABLE 100: JOHNSON & JOHNSON PRODUCT PORTFOLIO
    • TABLE 101: JOHNSON & JOHNSON DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • MEDTRONIC
    • TABLE 102: MEDTRONIC PRODUCT PORTFOLIO
    • TABLE 103: MEDTRONIC RECENT DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • NOVARTIS
    • TABLE 104: NOVARTIS PRODUCT PORTFOLIO
    • TABLE 105: NOVARTIS DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • OLYMPUS CORPORATION
    • TABLE 106: OLYMPUS CORP. PRODUCT PORTFOLIO
    • TABLE 107: OLYMPUS CORP. DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • PALL CORP.
    • TABLE 108: PALL CORP. PRODUCT PORTFOLIO
    • TABLE 109: PALL CORP. DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • PHILIPS HEALTHCARE
    • TABLE 110: PHILIPS PRODUCT PORTFOLIO
    • TABLE 111: PHILIPS DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • ROCHE DIAGNOSTICS
    • TABLE 112: ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
    • TABLE 113: ROCHE DIAGNOSTICS DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • SAINT JUDE MEDICAL
    • TABLE 114: SAINT JUDE MEDICAL PRODUCT PORTFOLIO
    • TABLE 115: SAINT JUDE MEDICAL DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • SIEMENS HEALTHCARE
    • TABLE 116: SIEMENS HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 117: SIEMENS HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • SMITH & NEPHEW
    • TABLE 118: SMITH & NEPHEW PRODUCT PORTFOLIO
    • TABLE 119: SMITH & NEPHEW DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • SMITHS MEDICAL
    • TABLE 120: SMITHS MEDICAL PRODUCT PORTFOLIO
    • TABLE 121: SMITHS MEDICAL DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • STRYKER CORP.
    • TABLE 122: STRYKER CORP. PRODUCT PORTFOLIO
    • TABLE 123: STRYKER CORP. DEVELOPMENTS, 2013-APRIL 2016
  • SYNTHES
    • TABLE 124 SYNTHES PRODUCT PORTFOLIO
  • TELEFLEX
    • TABLE 125: TELEFLEX PRODUCT PORTFOLIO
    • TABLE 126: TELEFLEX DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • THERMO FISHER SCIENTIFIC
    • TABLE 127: THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO
    • TABLE 128: THERMO FISHER SCIENTIFIC DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • TOSHIBA MEDICAL SYSTEMS CORP.
    • TABLE 129: TOSHIBA MEDICAL SYSTEMS PRODUCT PORTFOLIO
    • TABLE 130: TOSHIBA MEDICAL SYSTEMS DEVELOPMENTS, JANUARY 2013-APRIL 2016
  • ZIMMER HOLDINGS
    • TABLE 131: ZIMMER HOLDINGS PRODUCT PORTFOLIO
    • TABLE 132: ZIMMER HOLDINGS DEVELOPMENTS, JANUARY 2013-FEBRUARY 2016

CHAPTER 8 - PATENT ANALYSIS

  • TABLE 133: U.S. MEDICAL DEVICE TECHNOLOGY PATENTS, 2011-APRIL 2016
  • TABLE 134: EUROPEAN MEDICAL DEVICE TECHNOLGY PATENTS, 2011-APRIL 2016
  • TABLE 135: JAPANESE MEDICAL DEVICE TECHNOLOGY PATENTS, 2011-APRIL 2016

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 1: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGY BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 2: GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 3: GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 4: GLOBAL MARKET FOR MAGNETIC IMAGING RESONANCE TECHNOLOGY BY REGION,THROUGH 2021 ($ MILLIONS)
    • TABLE 5: GLOBAL MARKET FOR ULTRASOUND TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 6: GLOBAL MARKET FOR LASER IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 7: GLOBAL MARKET FOR INTERVENTIONAL RADIOLOGY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 8: GLOBAL MARKET FOR X-RAY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 9: TARGET DISEASE STATISTICS
    • TABLE 10: GLOBAL MARKET FOR COMPUTER TOMOGRAPHY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 11: GLOBAL MARKET FOR NUCLEAR MEDICINE/PET TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 12: GLOBAL MARKET FOR POINT-OF-CARE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 13: GLOBAL MARKET FOR POINT-OF-CARE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 14: GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY SEGMENTS, THROUGH 2021 ($ MILLIONS)
    • TABLE 16: GLOBAL MARKET FOR IMMUNOCHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 17: GLOBAL MARKET FOR CLINICAL CHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 18: POINT-OF-CARE DIAGNOSTIC TESTS AND MANUFACTURERS
    • TABLE 19: DIABETES INCIDENCE IN THE TOP 10 COUNTRIES, 2013 (THOUSANDS)
    • TABLE 20: GLOBAL MARKET FOR POINT-OF-CARE TESTING TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 21: POINT-OF-CARE DIAGNOSTIC SOLUTIONS ACROSS PRODUCT SEGMENTS
    • TABLE 22: GLOBAL MARKET FOR MOLECULAR DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 23: GLOBAL MARKET FOR HEMATOLOGY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 24: GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 25: ABLATION TYPES AND THEIR MECHANISMS
    • TABLE 26: GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 27: INCIDENCE OF RESTENOSIS BY STENT TYPE, 2014 (%)
    • TABLE 28: DRUG-ELUTING STENT PRODUCTS AND MANUFACTURERS
    • TABLE 29: BIO-ABSORBABLE STENT PRODUCTS AND MANUFACTURERS
    • TABLE 30: COMPARATIVE ANALYSIS OF STENTS BY BALLOON PLATFORM
    • TABLE 31: MANUFACTURERS AND THEIR PRODUCTS
    • TABLE 32: GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 33: ANTI-ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE
    • TABLE 34: ANTI-ARRHYTHMIC DRUG CLASSIFICATION AND CLINICAL USAGE
    • TABLE 35: GLOBAL MARKET FOR CARDIAC CATHETERIZATION TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 36: GLOBAL MARKET FOR ORTHOPEDIC AND SPINAL TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR ORTHOPEDIC AND SPINE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 39: GLOBAL MARKET FOR SPINE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 40: FDA AND CE APPROVALS OF SPINAL CORD STIMULATION DEVICES, 2001-2015
    • TABLE 41: GLOBAL MARKET FOR TRAUMA FIXATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 42: GLOBAL MARKET FOR ROBOTIC SYSTEM TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 43: GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 44: GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 45: GLOBAL MARKET FOR LITHOTRIPTER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 46: GLOBAL MARKET FOR INCONTINENCE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 47: GLOBAL MARKET FOR RENAL DIALYSIS DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 48: GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 49: GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 50: GLOBAL MARKET FOR RIGID ENDOSCOPIC DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 51: GLOBAL MARKET FOR FLEXIBLE ENDOSCOPIC DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 52: GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 53: GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 54: GLOBAL MARKET FOR INFUSION SYSTEM AND INJEC
    • TABLE DE: ICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 55: GLOBAL MARKET FOR INHALATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 56: GLOBAL MARKET FOR NEEDLE-FREE INJECTION AND TRANSDERMAL SYSTEM TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 57: MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES
    • TABLE 58: NORTH AMERICAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 59: EUROPEAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 60: ASIA-PACIFIC MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 61: REST OF THE WORLD MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS)
    • TABLE 62: PRODUCT LAUNCHES AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016
    • TABLE 63: MERGERS AND ACQUISITIONS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET, JANUARY 2013-SEPTEMBER 2016
    • TABLE 64: AGREEMENTS, JOINT VENTURES, EXPANSIONS, DIVESTMENTS AND INVESTMENTS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016
    • TABLE 65: CERTIFICATION, REORGANIZATION, RESEARCH AND DEVELOPMENT FACILITIES, AND SERVICES AND SOLUTIONS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016
    • TABLE 66: CERTIFICATIONS AND SERVICES IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016
    • TABLE 67: REORGANIZATION, COLLABORATION, SPINOFFS, RESEARCH AND DEVELOPMENT AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016
    • TABLE 68: 3M PRODUCT PORTFOLIO
    • TABLE 69: 3M DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 70: ABBOTT LABORATORIES PRODUCT PORTFOLIO
    • TABLE 71: ABBOTT LABORATORIES DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 72: AGILENT PRODUCT PORTFOLIO
    • TABLE 73: AGILENT DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 74: BAYER HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 75: BAYER HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 76: BAXTER INTERNATIONAL PRODUCT PORTFOLIO
    • TABLE 77: BAXTER INTERNATIONAL DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 78: BECKTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO
    • TABLE 79: BECKTON, DICKINSON AND COMPANY DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 80: BOSTON SCIENTIFIC PRODUCT PORTFOLIO
    • TABLE 81: BOSTON SCIENTIFIC DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 82: CARDINAL HEALTH PRODUCT PORTFOLIO
    • TABLE 83: CARDINAL HEALTH DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 84: COVIDIEN PRODUCT PORTFOLIO
    • TABLE 85: COVIDIEN DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 86: DANAHER PRODUCT PORTFOLIO
    • TABLE 87: DANAHER DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 88: DRAGER PRODUCT PORTFOLIO
    • TABLE 89: DRAGER DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 90: FRESENIUS PRODUCT PORTFOLIO
    • TABLE 91: FRESENIUS DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 92: GE HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 93: GE HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 94: GETINGE AB PRODUCT PORTFOLIO
    • TABLE 95: GETINGE AB DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 96: HALYARD HEALTH, INC. PRODUCT PORTFOLIO
    • TABLE 97: KIMBERLY-CLARK HEALTHCARE DEVELOPMENTS, JANUARY 2013-SEPTEMBER 2016
    • TABLE 98: HOSPIRA PRODUCT PORTFOLIO
    • TABLE 99 : OSPIRA DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 100: JOHNSON & JOHNSON PRODUCT PORTFOLIO
    • TABLE 101: JOHNSON & JOHNSON DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 102: MEDTRONIC PRODUCT PORTFOLIO
    • TABLE 103: MEDTRONIC RECENT DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 104: NOVARTIS PRODUCT PORTFOLIO
    • TABLE 105: NOVARTIS DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 106: OLYMPUS CORP. PRODUCT PORTFOLIO
    • TABLE 107: OLYMPUS CORP. DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 108: PALL CORP. PRODUCT PORTFOLIO
    • TABLE 109: PALL CORP. DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 110: PHILIPS PRODUCT PORTFOLIO
    • TABLE 111: PHILIPS DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 112: ROCHE DIAGNOSTICS PRODUCT PORTFOLIO
    • TABLE 113: ROCHE DIAGNOSTICS DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 114: SAINT JUDE MEDICAL PRODUCT PORTFOLIO
    • TABLE 115: SAINT JUDE MEDICAL DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 116: SIEMENS HEALTHCARE PRODUCT PORTFOLIO
    • TABLE 117: SIEMENS HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 118: SMITH & NEPHEW PRODUCT PORTFOLIO
    • TABLE 119: SMITH & NEPHEW DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 120: SMITHS MEDICAL PRODUCT PORTFOLIO
    • TABLE 121: SMITHS MEDICAL DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 122: STRYKER CORP. PRODUCT PORTFOLIO
    • TABLE 123: STRYKER CORP. DEVELOPMENTS, 2013-APRIL 2016
    • TABLE 124: SYNTHES PRODUCT PORTFOLIO
    • TABLE 125: TELEFLEX PRODUCT PORTFOLIO
    • TABLE 126: TELEFLEX DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 127: THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO
    • TABLE 128: THERMO FISHER SCIENTIFIC DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 129: TOSHIBA MEDICAL SYSTEMS PRODUCT PORTFOLIO
    • TABLE 130: TOSHIBA MEDICAL SYSTEMS DEVELOPMENTS, JANUARY 2013-APRIL 2016
    • TABLE 131: ZIMMER HOLDINGS PRODUCT PORTFOLIO
    • TABLE 132: ZIMMER HOLDINGS DEVELOPMENTS, JANUARY 2013-FEBRUARY 2016
    • TABLE 133: U.S. MEDICAL DEVICE TECHNOLOGY PATENTS, 2011-APRIL 2016
    • TABLE 134: EUROPEAN MEDICAL DEVICE TECHNOLGY PATENTS, 2011-APRIL 2016
    • TABLE 135: JAPANESE MEDICAL DEVICE TECHNOLOGY PATENTS, 2011-APRIL 2016

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, 2015-2021 ($ MILLIONS)
    • FIGURE 1: GLOBAL POPULATION OLDER THAN AGE 60 BY REGION, 2013
    • FIGURE 2: GLOBAL PROJECTED GROWTH OF DIABETES INCIDENCES IN PATIENTS AGE 20-79, 2010 AND 2030 (%)
    • FIGURE 3: GLOBAL INCIDENCE OF PATIENTS WITH CHRONIC DISEASES, 2005-2030 (MILLIONS)
    • FIGURE 4: GLOBAL MARKET SHARES OF KEY COMPANIES IN MAGNETIC IMAGING RESONANCE TECHNOLOGIES, 2015 (%)
    • FIGURE 5: COUNTRIES WITH THE HIGHEST PERCENTAGE OF PEOPLE AGE 60 AND OLDER, 2011
    • FIGURE 6: COUNTRIES WITH THE HIGHEST EXPECTED PERCENTAGE OF PEOPLE AGE 60 AND OLDER, 2050
    • FIGURE 7: GLOBAL MARKET SHARES OF ULTRASOUND TECHNOLOGIES BY COMPANY, 2015 (%)
    • FIGURE 8: GLOBAL PREVALENCE OF ALZHEIMER'S DISEASE BY REGION, 2010-2050
    • FIGURE 9: GLOBAL MARKET SHARES FOR LASER IMAGING BY COMPANY, 2015 (%)
    • FIGURE 10: GLOBAL ANGIOPLASTY PROCEDURES, 2009-2012
    • FIGURE 11: GLOBAL STENTS USED IN CORONARY PROCEDURES, 2009-2012 (NO. OF STENTS)
    • FIGURE 12: PICTURE ARCHIVING AND COMMUNICATION SYSTEM PROCESS FOR OBTAINING IMAGES
    • FIGURE 13: GLOBAL POPULATION BY AGE GROUP, 2000 AND 2050 (%)
    • FIGURE 14: GLOBAL MARKET SHARES FOR X-RAY SYSTEMS BY COMPANY, 2015 (%)
    • FIGURE 15: CORONARY HEART DISEASE IN SELECTED COUNTRIES, 2012 (%)
    • FIGURE 16: GLOBAL CARDIOVASCULAR MORTALITY BY INCOME LEVEL, 2011 (%)
    • FIGURE 17: HEALTHCARE EXPENDITURES IN THE U.S., CHINA AND INDIA, 2009-2011
    • FIGURE 18: GLOBAL MARKET SHARES FORIN VITRO DIAGNOSTICS BY COMPANY, 2015 (%)
    • FIGURE 19: GLOBAL MARKET SHARES FOR PROFESSIONAL DIAGNOSTICS BY COMPANY, 2015 (%)
    • FIGURE 20: CARDIOVASCULAR DISEASE IN SELECTED REGIONS, 2012 (%)
    • FIGURE 21: NEW GLOBAL HIV INFECTIONS BY REGION, 2012 (NO.)
    • FIGURE 22: GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR INFECTIOUS DISEASES, 2015 (%)
    • FIGURE 23: GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR HEPATITIS AND RETROVIRUS, 2015 (%)
    • FIGURE 24: GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR ONCOLOGY AND ENDOCRINOLOGY, 2015 (%)
    • FIGURE 25: GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR NUCLEIC ACID TESTING, 2015
    • FIGURE 26: GLOBAL PREVALENCE OF DIABETES BY AGE GROUP BY REGION, 2013 (THOUSANDS)
    • FIGURE 27: SHIFT IN USAGE OF POINT-OF-CARE DIAGNOSTIC SOLUTIONS
    • FIGURE 28: U.S. HOSPITAL HEALTHCARE SPENDING, 2010-2012 ($ BILLIONS)
    • FIGURE 29: GLOBAL MARKET SHARES FOR POINT-OF-CARE DIAGNOSTICS BY COMPANY, 2015 (%)
    • FIGURE 30: APPLICATION OF MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE SEGMENTS, 2015 (%)
    • FIGURE 31: GLOBAL MARKET SHARES FOR MOLECULAR DIAGNOSTICS BY COMPANY, 2015 (%)
    • FIGURE 32: GLOBAL POPULATION BY AGE GROUP, 2000 AND 2050 (%)
    • FIGURE 33: EVOLUTION OF CORONARY STENTS
    • FIGURE 34: GLOBAL POPULATION BASE TO AGE 65 AND OLDER, 2000 AND 2050 (%)
    • FIGURE 35: OSTEOPOROTIC HIP FRACTURES BY REGION, 1990 AND 2050 (THOUSANDS)
    • FIGURE 36: GLOBAL MARKET SHARES FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY COMPANY, 2015 (%)
    • FIGURE 37: GLOBAL MARKET SHARES FOR SPINAL IMPLANT BY COMPANY, 2015 (%)
    • FIGURE 38: GLOBAL MARKET SHARES FOR TRAUMA DEVICE FIXATION BY COMPANY, 2015
    • FIGURE 39: GLOBAL PREVALENCE OF KIDNEY DISEASE BY REGION, 2012 (%)
    • FIGURE 40: LIFE EXPECTANCY AT BIRTH FOR SELECTED COUNTRIES, 2012 (YEARS)
    • FIGURE 41: GLOBAL POPULATION BASE AGE 60 AND OLDER, 2010-2017 (%)
    • FIGURE 42: GLOBAL MARKET SHARES FOR OSTOMY CARE DEVICES BY COMPANY, 2015 (%)
    • FIGURE 43: GLOBAL MARKET SHARES FOR INCONTINENCE CARE DEVICES BY COMPANY, 2015 (%)
    • FIGURE 44: GLOBAL MARKET SHARES FOR RENAL DIALYSIS DEVICES BY COMPANY, 2015
    • FIGURE 45: GLOBAL PREVALENCE OF COLON CANCER BY AGE, 2015
Back to Top